search
Back to results

Postoperative Biliary Fistula Prevention After Hepatectomy

Primary Purpose

Hepatectomy

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
External Biliary duct stent in the bile duct by cystic way
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hepatectomy focused on measuring Biliary fistula, prevention, hepatectomy, external stent, Hepatectomy of more 2 segments, Not emergency or laparoscopy surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subject has given his informed consent and signed consent
  • Hepatectomy at least 2 segments of liver parenchyma for a benign or malignant disease by laparotomy
  • Not cirrhotic liver

Exclusion Criteria:

  • Surgery made in emergency
  • Surgery by laparoscopy
  • Need to draw up a bilic-digestive anastomosis
  • Liver cirrhosis
  • History of cholecystectomy
  • Resection of less than 2 segments
  • Preoperative jaundice (total bilirubin> 30 micromol / l)
  • Presence of preoperative biliary drainage
  • Patients requiring the installation of a drain transcystic during the operation

Sites / Locations

  • CHU
  • Hotel Dieu
  • Hôpital beaujon
  • Hôpital Claude Huriez
  • Institut Paoli Calmettes
  • CHU la conception
  • Hôpital St Eloi
  • Hotel Dieu
  • Hôpital Saint Antoine
  • hôpital Haute Pierre
  • Toulouse Purpan
  • Hôpital Paul Brousse

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

external biliary duct stent

without external biliary duct stent

Arm Description

'External Biliary duct stent in the bile duct by cystic way'

Outcomes

Primary Outcome Measures

Postoperative biliary fistula
3 forms of diagnosis : bile in the intra-abdominal drainage; presence of an intra-abdominal collection of bile liquid (biloma); presence of an effusion of bile in the abdominal space (biliary peritonitis).

Secondary Outcome Measures

Morbidity
additional maneuvers for treat biliary fistula, during of hospital stay, during of biliary fistula
Mortality

Full Information

First Posted
July 4, 2011
Last Updated
July 28, 2020
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT01469442
Brief Title
Postoperative Biliary Fistula Prevention After Hepatectomy
Official Title
Postoperative Biliary Fistula Prevention After Hepatectomy by External Biliary Duct Stent:Prospective Multicenter Randomized Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2020
Overall Recruitment Status
Completed
Study Start Date
May 2009 (undefined)
Primary Completion Date
September 2017 (Actual)
Study Completion Date
September 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Aim : Effect of external biliary duct stent after hepatectomy on the occurence of postoperative biliary fistula. Methods : French prospective multicenter randomized trial. Population study: Adult patients who underwent hepatectomy (> 2 segments) on non-cirrhotic liver. Hypothesis: decreased postoperative biliary fistula from 15% to 5% with the presence of a external biliary duct stent. With this hypothesis, the number of patients required to be equal to 152 per group for a total of 304 patients. Outcome measure: Primary : Postoperative biliary complications (biliary fistula, biloma, biliary peritonitis) Secondary : All morbidity, mortality, additional manoeuvres to treat biliary fistula, during of hospital stay and biliary fistula. Follow up: A follow-up of patients 3 months after surgery for all patients. The planned total duration of the study is 3 years and 3 months.
Detailed Description
After performing the hepatectomy and verification of hemostasis, patients were randomized (external biliary duct stent or not) by sealed envelopes. Systematic intraoperative test with methylene blue or air by the external biliary duct stent (EBDS) will necessary for all patients. Intra-abdominal drainage or not and type will be at the discretion of the surgeon. The EBDS will be left open for the first 7 postoperative days and then clamped. The EBDS will be removed during a consultation 5 weeks after surgery. Both groups of patients will be reviewed at 3 months after surgery, it will be noted at this point the possible complications related to the presence of EBDS (leakage from the drain, drop..). If patients are hospitalized more than five weeks, the study will stop at their consultation three months or the day of the consultation where the DTC is removed if it is still present at 3 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hepatectomy
Keywords
Biliary fistula, prevention, hepatectomy, external stent, Hepatectomy of more 2 segments, Not emergency or laparoscopy surgery

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
304 (Actual)

8. Arms, Groups, and Interventions

Arm Title
external biliary duct stent
Arm Type
Experimental
Arm Description
'External Biliary duct stent in the bile duct by cystic way'
Arm Title
without external biliary duct stent
Arm Type
No Intervention
Intervention Type
Procedure
Intervention Name(s)
External Biliary duct stent in the bile duct by cystic way
Intervention Description
The size of the external biliary duct stent depending of cystic duct size
Primary Outcome Measure Information:
Title
Postoperative biliary fistula
Description
3 forms of diagnosis : bile in the intra-abdominal drainage; presence of an intra-abdominal collection of bile liquid (biloma); presence of an effusion of bile in the abdominal space (biliary peritonitis).
Time Frame
3 months after surgey
Secondary Outcome Measure Information:
Title
Morbidity
Description
additional maneuvers for treat biliary fistula, during of hospital stay, during of biliary fistula
Time Frame
3 months after surgey
Title
Mortality
Time Frame
3 months after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subject has given his informed consent and signed consent Hepatectomy at least 2 segments of liver parenchyma for a benign or malignant disease by laparotomy Not cirrhotic liver Exclusion Criteria: Surgery made in emergency Surgery by laparoscopy Need to draw up a bilic-digestive anastomosis Liver cirrhosis History of cholecystectomy Resection of less than 2 segments Preoperative jaundice (total bilirubin> 30 micromol / l) Presence of preoperative biliary drainage Patients requiring the installation of a drain transcystic during the operation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fabrice MUSCARI, MD
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU
City
Amiens
ZIP/Postal Code
80054
Country
France
Facility Name
Hotel Dieu
City
Clermont Ferrand
ZIP/Postal Code
63003
Country
France
Facility Name
Hôpital beaujon
City
Clichy
ZIP/Postal Code
92118
Country
France
Facility Name
Hôpital Claude Huriez
City
Lille
ZIP/Postal Code
59037
Country
France
Facility Name
Institut Paoli Calmettes
City
Marseille
ZIP/Postal Code
13273
Country
France
Facility Name
CHU la conception
City
Marseille
ZIP/Postal Code
13385
Country
France
Facility Name
Hôpital St Eloi
City
Montpellier
ZIP/Postal Code
34295
Country
France
Facility Name
Hotel Dieu
City
Nantes
ZIP/Postal Code
44093
Country
France
Facility Name
Hôpital Saint Antoine
City
Paris
ZIP/Postal Code
75012
Country
France
Facility Name
hôpital Haute Pierre
City
Strasbourg
ZIP/Postal Code
67098
Country
France
Facility Name
Toulouse Purpan
City
Toulouse
ZIP/Postal Code
31000
Country
France
Facility Name
Hôpital Paul Brousse
City
Villejuif
ZIP/Postal Code
94804
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31916605
Citation
Maulat C, Regimbeau JM, Buc E, Boleslawski E, Belghiti J, Hardwigsen J, Vibert E, Delpero JR, Tournay E, Arnaud C, Suc B, Pessaux P, Muscari F. Prevention of biliary fistula after partial hepatectomy by transcystic biliary drainage: randomized clinical trial. Br J Surg. 2020 Jun;107(7):824-831. doi: 10.1002/bjs.11405. Epub 2020 Jan 9.
Results Reference
result

Learn more about this trial

Postoperative Biliary Fistula Prevention After Hepatectomy

We'll reach out to this number within 24 hrs